Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Vocimagene amiretrorepvec

EU orphan designation number: EU/3/18/1987   
Active ingredient: Vocimagene amiretrorepvec
Indication: Treatment of glioma
Sponsor: Richardson Associates Regulatory Affairs Ltd
22 Northumberland Road, Ballsbridge, Dublin 4 D04 ED73, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/02/2018 Orphan designation EMA/OD/185/17 (2018)1254 of 22/02/2018
19/12/2018 Transfer of orphan designation EMA/OD/0000002643 (2018)9006 of 14/12/2018